Načítá se...
Factors associated with optimized tacrolimus dosing in hematopoietic stem cell transplantation
OBJECTIVE: The primary objective was to analyze the initial tacrolimus concentrations achieved in allogeneic hematopoietic stem cell transplantation patients using the institutional dosing strategy of 1 mg IV daily initiated on day +5. The secondary objectives were to ascertain the tacrolimus dose,...
Uloženo v:
| Vydáno v: | J Oncol Pharm Pract |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4696901/ https://ncbi.nlm.nih.gov/pubmed/25802301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155215577809 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|